False Belief About Biological Sex & Mental Health

• The belief that one was “born in the wrong body” is a false belief or judgment about external reality, held despite incontrovertible evidence to the contrary.

• In clinical psychiatry, a fixed false belief about reality despite evidence is, by definition, a symptom of serious mental illness — DSM-5-TR: “A delusion is a false belief based on incorrect inference about external reality.”

• Biological sex is objectively observable and immutable at the chromosomal and reproductive level.

• Historically, medicine treats such conflicts with psychotherapy, not body modification.

Important distinction:

• Distress about one’s body is real & deserves care

• Affirming a false belief with irreversible medical interventions represents a departure from standard mental-health practice

WHO & APA Reclassifications Do NOT Prove Safety or Necessity

• WHO unjustly moved “gender incongruence” out of the mental‑disorders chapter in an attempt to reduce stigma, not due to new clinical evidence — “This change was not based on new scientific findings.” — WHO ICD‑11 Working Group Commentary

• APA also claims that gender dysphoria remains a diagnosable condition, dispite the evidence that it's a mental illness — “Gender nonconformity itself is not a mental disorder.” — DSM‑5‑TR

Classification ≠ proof of treatment safety or medical necessity.

Not Healthcare by Medical Definition

Healthcare interventions are generally expected to:

• Treat or cure disease

• Correct a pathological medical condition

• Prevent death or serious morbidity

• Demonstrate a favorable risk–benefit profile supported by strong evidence

Gender‑affirming medical interventions:

• Do not treat or cure a disease

• Do not correct an underlying pathological condition

• Do not prevent death

• Intentionally modify healthy anatomy for psychological reasons

“Medical interventions that permanently alter healthy organs without clear evidence of disease modification or mortality reduction cannot be considered medically necessary.” — NICE Evidence Review (UK)

Conclusion: Puberty blockers, cross‑sex hormones, and surgeries are best described as elective body‑modifying interventions, not healthcare.

Not Settled Science

• There is no high‑quality, long‑term evidence proving that medical gender transition (puberty blockers, cross‑sex hormones, surgeries) is safe or effective across populations. “The overall evidence base is of low certainty.” — BMJ Evidence‑Based Medicine, systematic review

• Most supportive studies are observational, rely on self‑reported outcomes, have short follow‑up, and lack proper control groups. “Most studies had methodological limitations and high risk of bias.” — JAMA Pediatrics

• Systematic reviews consistently rate the certainty of evidence as low to very low, meaning reliable conclusions cannot be drawn. “Confidence in effect estimates is low or very low.” — Cochrane Review

Treatments without robust evidence cannot reasonably be labeled “medically necessary.”

Again, classification ≠ proof of treatment safety or medical necessity.

Significant Safety Risks

Medical gender interventions introduce known and plausible harms documented in clinical literature:

Puberty Blockers:

• Suppression of normal pubertal development

• Potential impacts on bone density, brain development, and fertility — “Effects on bone mineral density and neurodevelopment remain uncertain.” — Endocrine Society Clinical

Practice Guideline:

• High rates of progression from blockers to cross‑sex hormones — “The majority of patients who received puberty blockers proceeded to gender‑affirming hormones.” — JAMA Pediatrics

Cross‑Sex Hormones:

• Sterilization or permanent fertility impairment — “Fertility may be compromised.” — Endocrine Society

• Cardiovascular risks — “Increased risk of thromboembolic events has been observed.” — Circulation (American Heart Association)

• Lifelong pharmaceutical patients (medical dependency)

Surgeries:

• Irreversible removal of healthy organs

• High complication and revision rates — “Reoperation rates remain clinically significant.” — Plastic and Reconstructive Surgery Journal

Key Point: These risks are acknowledged in medical guidelines, not speculative.

Mental‑Health Outcomes Are Unclear

• Claims that transition reduces suicide are not supported by causal evidence — “No study demonstrated that gender‑affirming treatment reduces suicide.” — BMJ Evidence‑Based Medicine

• Elevated rates of depression, anxiety, and suicidality persist post‑transition — “Mortality and suicide risk remain elevated.” — Swedish National Registry Study (Bränström et al.)

• No randomized controlled trials demonstrate durable mental‑health benefit — “Randomized trials are lacking.” — Cochrane Review

Conclusion: Psychological distress is not reliably resolved by medical transition.

Suicide, Mental Health, and Evidence Quality

• There is no strong evidence that gender‑affirming medical treatment reduces suicide deaths.

• The highest‑quality population‑level data comes from Finland’s national registry.

Finnish National Cohort Study:

• Tracked 2,083 gender‑referred adolescents

• Suicide mortality: 0.51 per 1,000 person‑years vs 0.12 per 1,000 in matched controls

• After adjustment for psychiatric history, the difference was not statistically significant

“No statistically significant reduction in suicide mortality was observed after adjustment.” — Acta Psychiatrica Scandinavica (2023)

• Smaller clinical or survey studies sometimes report reduced distress or suicidal ideation, but:

• Rely on self‑reported outcomes

• Use non‑randomized samples

• Have short follow‑up periods

“Evidence is limited by study design and reliance on self‑reported measures.” — JAMA Network Open (2022)

Key distinction: Reduced distress or ideation ≠ reduced suicide mortality.

International Medical Reviews Agree: Evidence Is Weak

Medical systems do not reverse guidelines when evidence is strong. Formal evidence reviews from multiple countries reached similar conclusions:

• United Kingdom (NICE, Cass Review): Evidence is of “very low certainty.”

• Sweden (NBHW): Risks outweigh potential benefits for minors.

• Finland (COHERE): Psychotherapy should be first-line treatment.

• France & Norway: Urge great medical caution due to insufficient evidence.

• Canada: Federal and provincial reviews acknowledge limited evidence and uncertainty.

• United States (HHS, 2025): A comprehensive federal review found weak evidence of benefit, significant and poorly tracked harms, and heavy reliance on low-certainty studies for puberty blockers, cross-sex hormones, and surgeries in youth.

Key point: Independent medical systems do not reverse or restrict care when evidence is strong. The international trend — now echoed by the U.S. government — reflects insufficient evidence, unresolved safety concerns, and lack of proven medical necessity.

Policy Clarifications (Bill 9 - Alberta)

Bill 9 does NOT:

• Ban gender care

• Remove sex education

• Exclude transgender students

Bill 9 DOES:

• Require parental notification

• Protect fairness in sports

• Ensure major decisions are not made without parental knowledge

Claims that such policies are “violent” or “life‑threatening” are not evidence‑based.

https://www.alberta.ca/protecting-youth-supporting-parents-and-safeguarding-female-sport

Family Involvement and Child Welfare

• There is no evidence that parental involvement harms children.

• Family support is one of the strongest protective factors for youth mental health.

“Strong family support is associated with better mental‑health outcomes in adolescents.” — American College of Family Physicians

Policies requiring parental notification or involvement are consistent with child‑welfare standards.

Puberty Blockers and Chemical Castration

• The drugs used as puberty blockers (GnRH agonists) are the same drug class used in some jurisdictions for chemical castration of sex offenders.

• Their mechanism is the suppression of gonadotropin release, halting sexual development.

“GnRH analogues suppress sex hormone production.” — Endocrine Society

Clinical relevance: The use of the same pharmacological mechanism underscores the seriousness, potency, and risk profile of these drugs — particularly in children.

As Young As 14 Years Old

There are documented cases and reports indicating minors in Canada have begun hormone treatment or gotten "top surgery" in their early teens.

Clinical research confirms referrals and prescriptions for hormone care

A major Canadian study called "Trans Youth CAN!" looked at "transgender and gender‑diverse adolescents" under 16 referred to medical clinics for gender‑affirming care. In that research, about 62.4 % of those youth were prescribed either hormone suppression or gender‑affirming hormone therapy at their clinic visit. Pediatrics: https://publications.aap.org/pediatrics/article-abstract/148/5/e2020047266/181329/Transgender-Youth-Referred-to-Clinics-for-Gender?redirectedFrom=fulltext&utm_source=chatgpt.com?autologincheck=redirected

This is actual clinical prescribing, not just social transition — meaning these minors were legally evaluated by "physicians" and given hormone‑related "medical care" as part of their treatment.

Known and reported youngest ages:

Data from the Canadian Institute for Health Information shows that minors (under 18) have undergone “top surgery” (double mastectomies) as young as 14 years old in Canada — based on compiled hospital and surgical data. The Bridge Head: https://thebridgehead.ca/2023/10/23/hundreds-of-teen-girls-in-canada-have-undergone-double-mastectomies-due-to-gender-ideology/?utm_source=chatgpt.com

14‑year‑olds have been documented receiving hormone treatment in Canada.

A 14‑year‑old in Quebec was reported as being placed on puberty blockers and then cross‑sex hormones as a teenager. True North News: https://tnc.news/2024/03/07/quebec-teens-rushed-into-gender-transitions/?utm_source=chatgpt.com

British Columbia court case confirms a 14‑year‑old continued hormone treatment.

B.C.’s Court of Appeal ruled that a 14‑year‑old could continue hormone treatment despite a parent’s objection, which shows hormone therapy was already underway at that age. ARPA Canada: https://arpacanada.ca/articles/b-c-s-highest-court-says-14-year-old-can-continue-hormone-treatment-despite-gaps-in-risk-disclosure/?utm_source=chatgpt.com

Research context

Large clinic studies in Canada include transgender youth under age 16 who were referred for hormone therapy or blockers — meaning children as young as the early teens were included in medical care pathways. Pediatrics: https://publications.aap.org/pediatrics/article-abstract/148/5/e2020047266/181329/Transgender-Youth-Referred-to-Clinics-for-Gender?redirectedFrom=fulltext&utm_source=chatgpt.com?autologincheck=redirected

What this means in practice

Clinical practice does not set a hard national age minimum in most provinces for hormone therapy; local clinics "follow medical standards and assess maturity and consent ability." House of Commons: https://www.ourcommons.ca/DocumentViewer/en/42-1/hesa/meeting-141/evidence?utm_source=chatgpt.com

Individual experiences vary, but cases of hormone therapy beginning around age 14 are documented through reporting and legal decisions.

Unfortunately, trans-idenfied minors can & still do access hormone therapy treatments in Canada. Anyone claiming otherwise is either not aware of the facts, or they're simply denying them.

Since Canada has a publicly funded healthcare system, medically necessary procedures—including some forms of gender‑affirming care—are covered under provincial and territorial health insurance plans.

Most provinces and territories include gender‑affirming surgeries and hormone therapy as insured services under public health plans, though specific conditions and eligibility rules apply. (ohtn.on.ca)

However, what is deemed “medically necessary” differs depending on the jurisdiction.

The process and criteria for coverage varies by province and territory, with most requiring surgical readiness assessments and documented gender dysphoria. (canada.ca)

What Is Covered?

Hormone therapy (e.g., estrogen, testosterone)

Hormone therapy is covered in some provinces and territories under public drug insurance plans, though coverage details can vary. (canada.ca)

Some gender‑affirming surgeries (e.g., mastectomy/top surgery, genital/bottom surgery)

A recent cross‑sectional analysis found that across Canada’s provinces and territories:

• There are 32 unique gender‑affirming procedures covered to varying degrees across Canadian public plans. (pubmed.ncbi.nlm.nih.gov)

• Mastectomy and genital surgeries are widely covered — these types of surgeries have the most consistent coverage across provinces and territories. (pmc.ncbi.nlm.nih.gov)

Mental health assessments required for surgery approval

Most provinces and territories require surgical readiness and gender dysphoria documentation from qualified health professionals before covering surgery. (canada.ca)

What Is Not Always Covered?

Facial feminization surgery (FFS), voice surgery, hair removal, chest contouring for transmasculine individuals. Coverage of these procedures is far less common:

• Only a few provinces cover voice therapy or hair removal, and facial feminization is usually not publicly funded. (bmchealthservres.biomedcentral.com)

• Procedures considered cosmetic typically require private insurance or out-of-pocket payment. (canada.ca)

Provincial Variations

Ontario: OHIP covers gender‑affirming surgery (including chest and genital procedures) for eligible individuals after assessment and approval. (ontario.ca)

British Columbia: Through MSP and Trans Care BC, BC covers a range of gender‑affirming surgeries publicly, though some procedures may be limited or subject to criteria. (transcarebc.ca)

Alberta: Alberta’s Gender Surgery Program covers many major surgeries, but not all procedures and some are classified as uninsured services. (pmc.ncbi.nlm.nih.gov)

Prince Edward Island & Yukon: PEI and Yukon have among the most comprehensive coverage for gender‑affirming procedures, including some facial and cosmetic care not widely covered elsewhere. (bmchealthservres.biomedcentral.com)

Estimated Total Public Spending in Canada

Based on utilization estimates:

• Hormone therapy for ~25,000 patients: ~$37.5 million/year

• Top surgery (~2,500/year): ~$31.25 million/year

• Bottom surgery (~1,000/year): ~$32.5 million/year

• Mental health assessments/follow-ups: ~$25 million/year

Total estimated annual taxpayer-funded spending: $120–130 million/year

This figure includes hormone therapy and surgical procedures, but excludes cosmetic procedures. It represents a significant allocation of public funds toward interventions that are not proven to be medically necessary healthcare.

In Canada, there are alternatives to gender-affirming medical care that focus on mental health, coping skills, and reversible strategies rather than hormones or surgery.

Some approaches include:

• Counseling or therapy for anxiety, depression, or body image concerns without affirming medical transition

• Peer and community support groups that provide social connection and guidance while respecting individual choices

• Non-medical coping strategies such as voice coaching, clothing adjustments, and other reversible expression techniques

For individuals who have transitioned and are reconsidering or detransitioning, there are dedicated support networks, including:

• Beyond Trans – therapist-facilitated online groups for detransitioners (beyondtrans.org)

• Detrans.ai – online peer community and resources (detrans.ai)

• Detrans Voices – stories and support for detransitioners (detransvoices.org)

• DeTrans Alliance Canada – Canadian support and advocacy for detransitioners (detransalliancecanada.com)

Life can bring deep questions about identity, purpose, and belonging. Many seek answers in medicine or social strategies, but the Bible points us to the ultimate guide: Jesus Christ.

He sees our struggles, heals the brokenhearted (Psalm 34:18; Psalm 147:3), and offers wisdom for every decision (Proverbs 3:5-6). Our value is not defined by appearance or past choices, but by God’s love through Jesus (John 3:16). In Him, we find true guidance, peace, and strength, for “the truth will set you free” (John 8:32).

If you’re skeptical or questioning, message me—let’s connect and discuss the evidence of the Bible. Ask all the hard questions; no topic is off-limits.

Ryan James Larche | DIRT Ministry:

https://www.facebook.com/share/1A94je82Pe/